Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat
- 26 May 1999
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 409 (2) , 187-209
- https://doi.org/10.1002/(sici)1096-9861(19990628)409:2<187::aid-cne2>3.0.co;2-p
Abstract
Light and electron microscope immunocytochemistry with a monoclonal antibody against the N‐terminal domain of the human protein was used to determine the cellular and subcellular localization of serotonin 5‐HT2A receptors in the central nervous system of adult rat. Following immunoperoxidase or silver‐intensified immunogold labeling, neuronal, somatodendritic, and/or axonal immunoreactivity was detected in numerous brain regions, including all those in which ligand binding sites and 5‐HT2A mRNA had previously been reported. The distribution of 5‐HT2A‐immunolabeled soma/dendrites was characterized in cerebral cortex, olfactory system, septum, hippocampal formation, basal ganglia, amygdala, diencephalon, cerebellum, brainstem, and spinal cord. Labeled axons were visible in every myelinated tract known to arise from immunoreactive cell body groups. In immunopositive soma/dendrites as well as axons, the 5‐HT2A receptor appeared mainly cytoplasmic rather than membrane bound. Even though the dendritic labeling was generally stronger than the somatic, it did not extend to dendritic spines in such regions as the cerebral and piriform cortex, the neostriatum, or the molecular layer of the cerebellum. Similarly, there were no labeled axon terminals in numerous regions known to be strongly innervated by the immunoreactive somata and their axons (e.g., molecular layer of piriform cortex). It was concluded that the 5‐HT2A receptor is mostly intracellular and transported in dendrites and axons, but does not reach into dendritic spines or axon terminals. Because it has previously been shown that this serotonin receptor is transported retrogradely as well as anterogradely, activates intracellular transduction pathways and intervenes in the regulation of the expression of many genes, it is suggested that one of its main functions is to participate in retrograde signaling systems activated by serotonin. J. Comp. Neurol. 409:187–209, 1999.Keywords
This publication has 119 references indexed in Scilit:
- Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteinsBrain Research, 1997
- Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: Effect of 5,7-dihydroxytryptamineSynapse, 1997
- Identification of an Endogenous 5‐Hydroxytryptamine2A Receptor in NIH‐3T3 Cells: Agonist‐Induced Down‐Regulation Involves Decreases in Receptor RNA and NumberJournal of Neurochemistry, 1997
- Localization of 5‐HT2A receptor mRNA by in situ hybridization in the olfactory bulb of the postnatal ratJournal of Comparative Neurology, 1995
- Neurons Expressing 5-HT2 Receptors in the Rat Brain: Neurochemical Identification of Cell Types by ImmunocytochemistryNeuropsychopharmacology, 1994
- Excitatory responses to serotonin (5‐HT) in neurons of the rat piriform cortex: Evidence for mediation by 5‐HT1C receptors in pyramidal cells and 5‐HT2 receptors in interneuronsSynapse, 1991
- Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI)Neuroscience Letters, 1990
- Ultrastructural relationships of serotonin axon terminals in the cerebral cortex of the adult ratJournal of Comparative Neurology, 1989
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agentsLife Sciences, 1984